_tcm18-9556.gif )
High impact applications, properties and synthesis of exciting new materials
Also of interest
Physics, chemistry and biology of Soft Matter
Subscribers
Non-subscribers
- Purchase article PDF [£27 + taxes]
- Purchase article PDF member offer [£5 + taxes]
Free access
Paper
J. Mater. Chem., 2009, 19, 8385 - 8392, DOI: 10.1039/b914379c
Smart delivery of antitumoral platinum complexes from biomimetic hydroxyapatite nanocrystals
Michele Iafisco, Barbara Palazzo, Marco Marchetti, Nicola Margiotta, Rosa Ostuni, Giovanni Natile, Margherita Morpurgo, Valentina Gandin, Cristina Marzano and Norberto Roveri
This study widens the role of biomimetic hydroxyapatite (HA) nanocrystals as bone substitutes and describes how they can be used as bone-specific drug delivery devices for in situ treatment of bone tumors upon local implantation. The adsorption and release kinetics of bis-{ethylenediamineplatinum(II)}-2-amino-1-hydroxyethane-1,1-diyl-bisphosphonate and bis-{ethylenediamineplatinum(II)}medronate on two kinds of HA nanocrystals having different morphologies, crystallinity degrees and surface areas have been investigated. The different chemical structures of the two Pt complexes appreciably affect not only the affinity towards the two kinds of HA, but also their release. The Pt complex loading is slightly greater for the HA characterized by lower crystallinity and higher surface area, with respect to the more crystalline one. The cytotoxicity of Pt complexes released from the HA were tested against human cervix carcinoma cells and, interestingly, were found to be more cytotoxic than the unmodified complexes. The released Pt species are therefore the active dichloridoethylenediamineplatinum(II) or related solvato species formed by Pt-bisphosphonate bond breaking.
RSS feed